ramatroban has been researched along with sotalol in 1 studies
| Studies (ramatroban) | Trials (ramatroban) | Recent Studies (post-2010) (ramatroban) | Studies (sotalol) | Trials (sotalol) | Recent Studies (post-2010) (sotalol) |
|---|---|---|---|---|---|
| 142 | 10 | 28 | 2,196 | 346 | 291 |
| Protein | Taxonomy | ramatroban (IC50) | sotalol (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 3.8169 | |
| Beta-1 adrenergic receptor | Homo sapiens (human) | 7.1087 | |
| Beta-3 adrenergic receptor | Homo sapiens (human) | 7.2 | |
| Beta-2 adrenergic receptor | Canis lupus familiaris (dog) | 5.0667 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Francis, HP; Gardiner, PJ; Morris, TG; Patel, UP; Thompson, AM | 1 |
1 other study(ies) available for ramatroban and sotalol
| Article | Year |
|---|---|
The thromboxane receptor antagonist BAY u3405 reverses prostaglandin D2 (PGD2)-induced bronchoconstriction in the anaesthetised guinea pig.
Topics: Animals; Bronchoconstriction; Carbazoles; Dose-Response Relationship, Drug; Guinea Pigs; Indomethacin; Lung Volume Measurements; Male; Prostaglandin D2; Receptors, Prostaglandin; Receptors, Thromboxane; Sotalol; Sulfonamides; Thromboxanes | 1991 |